Chinese inhibitor drug candidate becomes first to enter phase
Release time：2024-04-30 03:47:31 Source：Cultural Carousel news portal
Chinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chinese regulatory authorities for the registration phase-3 clinical trial of a combination therapy using its SHP2 inhibitor drug candidate JAB-3312.
SHP2 inhibitors are expected worldwide to have a substantial clinical effect in cancer and immunity disease treatment, and the approval made JAB-3312 the first SHP2 inhibitor to enter the phase-3 clinical study globally.
The approved clinical study in China is designed to evaluate the efficacy and safety of JAB-3312 in combination with the company's other investigational drug candidate KRAS G12C inhibitor glecirasib, for treating first-line non-small cell lung cancer patients with KRAS G12C mutations.
The control arm is the current standard treatment for first-line non-small cell lung cancer, which is the combination therapy of PD-1 antibody and chemotherapy.
- Previous：Chemical and biological methods help restore ancient books in north China
- Next：Rolling Stones show no signs of slowing during latest tour in Texas
Related articles
- China rejects US accusations over normal China
- China willing to expand cooperation with Australia: Wang Yi
- Beijing slams Washington for spreading false info
- UN Security Council adopts first cease
- Insider Q&A: Avelo Airlines CEO Andrew Levy describes the challenges of starting a new carrier
- Xi meets Merieux Foundation president and his wife
- China condemns terrorist attack in Pakistan
- Truce remains elusive in Gaza as talks fall flat
- Rolling Stones show no signs of slowing during latest tour in Texas
- China, Dominica to boost ties
- President Xi on global, regional security
- CPC leadership reviews disciplinary inspection report
- Washington urged to respect rule of law in Hong Kong
- Insights丨German expert: Chancellor Scholz’s second visit to China signals the importance of Germany
- Overseas Chinese history museum opens new branch in S. China
- China intensifies efforts for cease
- UN's Gaza resolution welcomed
- Top political advisor highlights readiness to deepen relations with DPRK
- 2 policemen killed, 1 injured in 'terror' attack in SE Iran
- Washington urged to respect rule of law in Hong Kong
Random recommendation
- Copyright © 2024 Powered by Chinese inhibitor drug candidate becomes first to enter phase ,Cultural Carousel news portal sitemap